Stay updated with breaking news from Temporary Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ABIONYX Pharma announced new positive results in ophthalmology for the first class of CER-001-based biomedicines for the treatment of ocular pathologies, and the appointment of Mr. Jérôme Martinez...
Positive results on primary and secondary endpoints, identifying dose for future development Direct and significant effect of CER-001 on endotoxin removal and consequent reduction in the inflammatory
SpaceX may begin deploying second-gen Starlink satellites this month, according to regulatory filings.
EMA D120 Responses submitted in October as planned Two successful engineering batches of LUMEVOQ validate actions taken to correct low yields in previous runs €13.9 million of cash
Ramp up of sales marketing actions and investments to drive commercial launch of LUMEVOQ in Europe in 2023 Cash runway confirmed to early Q1 2023 Advanced discussions on refinancing